aluates Reports

$ 0.0

Automative

Global Gene Therapies for Tumor Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-4D14276

Global Gene Therapies for Tumor Treatment Market Research Report 2023

BUY CHAPTERS

Global Gene Therapies for Tumor Treatment Market Research Report 2025

Code: QYRE-Auto-4D14276

Report

September 2025

Pages:61

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Amgen Inc

Shanghai Sunway

Sibiono

Gilead Sciences

Gene Therapies for Tumor Treatment Market Size

The global market for Gene Therapies for Tumor Treatment was valued at US$ 7976 million in the year 2024 and is projected to reach a revised size of US$ 28260 million by 2031, growing at a CAGR of 20.1% during the forecast period.

Gene Therapies for Tumor Treatment Market

Gene therapy is the therapeutic delivery of nucleic acid into a patient"s cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.

The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.

This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Tumor Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Tumor Treatment.

The Gene Therapies for Tumor Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapies for Tumor Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapies for Tumor Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapies for Tumor Treatment Market Report

Report Metric	Details
Report Name	Gene Therapies for Tumor Treatment Market
Accounted market size in year	US$ 7976 million
Forecasted market size in 2031	US$ 28260 million
CAGR	20.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Gene Induced Immunotherapy Oncolytic Virotherapy Gene Transfer
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Gilead Sciences, Amgen, Shanghai Sunway, Sibiono
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Tumor Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Therapies for Tumor Treatment Market growing?

Ans: The Gene Therapies for Tumor Treatment Market witnessing a CAGR of 20.1% during the forecast period 2025-2031.

What is the Gene Therapies for Tumor Treatment Market size in 2031?

Ans: The Gene Therapies for Tumor Treatment Market size in 2031 will be US$ 28260 million.

Who are the main players in the Gene Therapies for Tumor Treatment Market report?

Ans: The main players in the Gene Therapies for Tumor Treatment Market are Novartis, Gilead Sciences, Amgen, Shanghai Sunway, Sibiono

What are the Application segmentation covered in the Gene Therapies for Tumor Treatment Market report?

Ans: The Applications covered in the Gene Therapies for Tumor Treatment Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Gene Therapies for Tumor Treatment Market report?

Ans: The Types covered in the Gene Therapies for Tumor Treatment Market report are Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer

Recommended Reports

Gene Therapy Platforms

Cancer Immunotherapy

Gene Editing Tools

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gene Induced Immunotherapy

1.2.3 Oncolytic Virotherapy

1.2.4 Gene Transfer

1.3 Market by Application

1.3.1 Global Gene Therapies for Tumor Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapies for Tumor Treatment Market Perspective (2020-2031)

2.2 Global Gene Therapies for Tumor Treatment Growth Trends by Region

2.2.1 Global Gene Therapies for Tumor Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapies for Tumor Treatment Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapies for Tumor Treatment Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapies for Tumor Treatment Market Dynamics

2.3.1 Gene Therapies for Tumor Treatment Industry Trends

2.3.2 Gene Therapies for Tumor Treatment Market Drivers

2.3.3 Gene Therapies for Tumor Treatment Market Challenges

2.3.4 Gene Therapies for Tumor Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue

3.1.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue (2020-2025)

3.1.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapies for Tumor Treatment Revenue

3.4 Global Gene Therapies for Tumor Treatment Market Concentration Ratio

3.4.1 Global Gene Therapies for Tumor Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2024

3.5 Global Key Players of Gene Therapies for Tumor Treatment Head office and Area Served

3.6 Global Key Players of Gene Therapies for Tumor Treatment, Product and Application

3.7 Global Key Players of Gene Therapies for Tumor Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapies for Tumor Treatment Breakdown Data by Type

4.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Type (2026-2031)

5 Gene Therapies for Tumor Treatment Breakdown Data by Application

5.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapies for Tumor Treatment Market Size (2020-2031)

6.2 North America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapies for Tumor Treatment Market Size by Country (2020-2025)

6.4 North America Gene Therapies for Tumor Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapies for Tumor Treatment Market Size (2020-2031)

7.2 Europe Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapies for Tumor Treatment Market Size by Country (2020-2025)

7.4 Europe Gene Therapies for Tumor Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapies for Tumor Treatment Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapies for Tumor Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapies for Tumor Treatment Market Size (2020-2031)

9.2 Latin America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2020-2025)

9.4 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapies for Tumor Treatment Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Gene Therapies for Tumor Treatment Introduction

11.1.4 Novartis Revenue in Gene Therapies for Tumor Treatment Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Details

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences Gene Therapies for Tumor Treatment Introduction

11.2.4 Gilead Sciences Revenue in Gene Therapies for Tumor Treatment Business (2020-2025)

11.2.5 Gilead Sciences Recent Development

11.3 Amgen

11.3.1 Amgen Company Details

11.3.2 Amgen Business Overview

11.3.3 Amgen Gene Therapies for Tumor Treatment Introduction

11.3.4 Amgen Revenue in Gene Therapies for Tumor Treatment Business (2020-2025)

11.3.5 Amgen Recent Development

11.4 Shanghai Sunway

11.4.1 Shanghai Sunway Company Details

11.4.2 Shanghai Sunway Business Overview

11.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Introduction

11.4.4 Shanghai Sunway Revenue in Gene Therapies for Tumor Treatment Business (2020-2025)

11.4.5 Shanghai Sunway Recent Development

11.5 Sibiono

11.5.1 Sibiono Company Details

11.5.2 Sibiono Business Overview

11.5.3 Sibiono Gene Therapies for Tumor Treatment Introduction

11.5.4 Sibiono Revenue in Gene Therapies for Tumor Treatment Business (2020-2025)

11.5.5 Sibiono Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Amgen Inc

Shanghai Sunway

Sibiono

Gilead Sciences

List of Tables

Table 1. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gene Induced Immunotherapy

Table 3. Key Players of Oncolytic Virotherapy

Table 4. Key Players of Gene Transfer

Table 5. Global Gene Therapies for Tumor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Therapies for Tumor Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gene Therapies for Tumor Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gene Therapies for Tumor Treatment Market Share by Region (2020-2025)

Table 9. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gene Therapies for Tumor Treatment Market Share by Region (2026-2031)

Table 11. Gene Therapies for Tumor Treatment Market Trends

Table 12. Gene Therapies for Tumor Treatment Market Drivers

Table 13. Gene Therapies for Tumor Treatment Market Challenges

Table 14. Gene Therapies for Tumor Treatment Market Restraints

Table 15. Global Gene Therapies for Tumor Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gene Therapies for Tumor Treatment Market Share by Players (2020-2025)

Table 17. Global Top Gene Therapies for Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2024)

Table 18. Ranking of Global Top Gene Therapies for Tumor Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gene Therapies for Tumor Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gene Therapies for Tumor Treatment, Headquarters and Area Served

Table 21. Global Key Players of Gene Therapies for Tumor Treatment, Product and Application

Table 22. Global Key Players of Gene Therapies for Tumor Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gene Therapies for Tumor Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Gene Therapies for Tumor Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gene Therapies for Tumor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gene Therapies for Tumor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gene Therapies for Tumor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gene Therapies for Tumor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gene Therapies for Tumor Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gene Therapies for Tumor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gene Therapies for Tumor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Novartis Company Details

Table 48. Novartis Business Overview

Table 49. Novartis Gene Therapies for Tumor Treatment Product

Table 50. Novartis Revenue in Gene Therapies for Tumor Treatment Business (2020-2025) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Gilead Sciences Company Details

Table 53. Gilead Sciences Business Overview

Table 54. Gilead Sciences Gene Therapies for Tumor Treatment Product

Table 55. Gilead Sciences Revenue in Gene Therapies for Tumor Treatment Business (2020-2025) & (US$ Million)

Table 56. Gilead Sciences Recent Development

Table 57. Amgen Company Details

Table 58. Amgen Business Overview

Table 59. Amgen Gene Therapies for Tumor Treatment Product

Table 60. Amgen Revenue in Gene Therapies for Tumor Treatment Business (2020-2025) & (US$ Million)

Table 61. Amgen Recent Development

Table 62. Shanghai Sunway Company Details

Table 63. Shanghai Sunway Business Overview

Table 64. Shanghai Sunway Gene Therapies for Tumor Treatment Product

Table 65. Shanghai Sunway Revenue in Gene Therapies for Tumor Treatment Business (2020-2025) & (US$ Million)

Table 66. Shanghai Sunway Recent Development

Table 67. Sibiono Company Details

Table 68. Sibiono Business Overview

Table 69. Sibiono Gene Therapies for Tumor Treatment Product

Table 70. Sibiono Revenue in Gene Therapies for Tumor Treatment Business (2020-2025) & (US$ Million)

Table 71. Sibiono Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

Table 75. Authors List of This Report

List of Figures

Figure 1. Gene Therapies for Tumor Treatment Picture

Figure 2. Global Gene Therapies for Tumor Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapies for Tumor Treatment Market Share by Type: 2024 VS 2031

Figure 4. Gene Induced Immunotherapy Features

Figure 5. Oncolytic Virotherapy Features

Figure 6. Gene Transfer Features

Figure 7. Global Gene Therapies for Tumor Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gene Therapies for Tumor Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. Gene Therapies for Tumor Treatment Report Years Considered

Figure 13. Global Gene Therapies for Tumor Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Gene Therapies for Tumor Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Gene Therapies for Tumor Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Gene Therapies for Tumor Treatment Market Share by Players in 2024

Figure 17. Global Top Gene Therapies for Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Gene Therapies for Tumor Treatment Revenue in 2024

Figure 19. North America Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Gene Therapies for Tumor Treatment Market Share by Country (2020-2031)

Figure 21. United States Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gene Therapies for Tumor Treatment Market Share by Country (2020-2031)

Figure 25. Germany Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gene Therapies for Tumor Treatment Market Share by Region (2020-2031)

Figure 33. China Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gene Therapies for Tumor Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Gene Therapies for Tumor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Novartis Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2020-2025)

Figure 49. Gilead Sciences Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2020-2025)

Figure 50. Amgen Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2020-2025)

Figure 51. Shanghai Sunway Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2020-2025)

Figure 52. Sibiono Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene Therapy For Cancer Market Research Report 2024

Global Gene Therapy in Oncology Market Research Report 2024

Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Cell and Gene Therapy Market Research Report 2024

Global Gene Therapy for Inherited Genetic Disorders Market Insights Forecast to 2030

Global Human Gene Therapy Market Research Report 2025

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Global Gene based Therapy Medicinal Market Research Report 2024

Global Genetic Modification Therapies Market Insights Forecast to 2030

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell and Gene Therapy Services Market Research Report 2024

Cell and Gene Therapy Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions